Search results for "Risk factor."

showing 10 items of 4316 documents

Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.

2009

OBJECTIVE: Dyslipidaemia is very common in patients with polycystic ovary syndrome (PCOS) but, beyond plasma lipids, atherogenic lipoprotein (Lp) and apolipoprotein (apo) alterations are still ill defined. DESIGN: We measured concentrations of apoB, Lp(a) and small, dense low-density lipoprotein (LDL) in 42 patients with PCOS [age: 28 +/- 7 years, body mass index (BMI): 27 +/- 5 kg/m(2)] vs. 37 age- and BMI-matched healthy controls. METHODS: Elevated Lp(a) levels considered were those > 30 mg/dl while elevated apoB concentrations were those > 100 g/l. RESULTS: Polycystic ovary syndrome showed increased triglycerides levels (p = 0.0011) and lower high-density lipoprotein (HDL)-cholesterol co…

Adultmedicine.medical_specialtySettore MED/09 - Medicina InternaApolipoprotein B10265 Clinic for Endocrinology and Diabetology610 Medicine & health2700 General MedicineSettore MED/13 - EndocrinologiaBody Mass Indexchemistry.chemical_compoundYoung AdultRisk FactorsInternal medicinemedicinedyslipidemia lipoproteins polycystic ovary syndromeHumansProspective cohort studyApolipoproteins BDyslipidemiasbiologyCholesterolbusiness.industryVascular diseaseCase-control studynutritional and metabolic diseasesGeneral MedicineCholesterol LDLmedicine.diseasePolycystic ovaryEndocrinologychemistry10036 Medical ClinicCardiovascular DiseasesCase-Control Studiesbiology.proteinlipids (amino acids peptides and proteins)FemalebusinessBody mass indexLipoproteinLipoprotein(a)Polycystic Ovary SyndromeInternational journal of clinical practice
researchProduct

Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome.

2008

Abstract BACKGROUND: Dyslipidemia is a common metabolic complication in polycystic ovary syndrome (PCOS). The aim of this study was to determine if differences exist in dyslipidemia in women with PCOS from different ethnic and geographical backgrounds. METHODS: This retrospective study evaluated the serum fasting lipid profiles of 106 women with PCOS from the United States and 108 women with PCOS from Italy evaluated at endocrinology clinics. RESULTS: American women had higher mean body mass index than Italian women (36.1+/-8.6 vs 28.1+/-5.8 kg/m2, p<0.01). Low HDL-cholesterol was the most prevalent lipid abnormality in both populations. U.S. women had higher mean levels of serum total chol…

Adultmedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismEthnic groupPhysiologySettore MED/13 - EndocrinologiaBody Mass IndexCohort StudiesEndocrinologyRisk FactorsmedicinePrevalenceHumansObesityPCOS Hyperandrogenism Cardiovascular risk dyslipidemia LDL-cholesterolDyslipidemiasRetrospective StudiesGynecologybusiness.industryRetrospective cohort studyOverweightmedicine.diseaseObesityPolycystic ovarySettore MED/40 - Ginecologia E OstetriciaLipidsConfidence intervalUnited StatesItalyCardiovascular DiseasesFemalebusinessBody mass indexDyslipidemiaCohort studyPolycystic Ovary SyndromeJournal of endocrinological investigation
researchProduct

Coincidence of nonpuerperal mastitis and noninflammatory breast cancer.

2002

Abstract Background : Nonpuerperal mastitis may mimic breast cancer but the incidence of noninflammatory cancer among such patients is unknown. Aim : To estimate the risk of breast cancer in patients with nonpuerperal mastitis within 12 months of treatment. Study design : Two hundred seventy-seven patients with nonpuerperal breast inflammation were prospectively screened for breast cancer within 1 year after mastitis was diagnosed. The age-related standardized breast cancer incidence ratio of the female population was calculated. Results : Five women (35, 43, 47, 61, and 72 years, respectively) were identified as having noninflammatory breast cancer independently, and at a location distant …

Adultmedicine.medical_specialtyTime FactorsBreast NeoplasmsMastitisInflammatory breast cancerBreast cancerRisk FactorsInternal medicineGermanymedicineHumansProspective StudiesRisk factorskin and connective tissue diseasesAgedGynecologyNonpuerperal mastitisbusiness.industryIncidence (epidemiology)Obstetrics and GynecologyCancerMiddle Agedmedicine.diseaseMastitisReproductive MedicinePopulation studyFemalebusinessEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

The effect of prenatal lifestyle intervention on weight retention 12 months postpartum: results of the Norwegian Fit for Delivery randomised controll…

2015

Objective To examine the effect of a prenatal lifestyle intervention on postpartum weight retention (PPWR). Design Randomised controlled trial. Setting Healthcare clinics in southern Norway. Population Healthy, nulliparous women with body mass index ≥19 kg/m2 , age ≥18 years, and singleton pregnancy of ≤20 gestational weeks. Methods Women were randomised to intervention (dietary counselling twice by phone and access to twice-weekly exercise groups during pregnancy) or control group (standard prenatal care). Intervention compliance was defined post-factum as attending dietary counselling and ≥14 exercise classes. Main outcome measures PPWR (weight measured postpartum minus self-reported pre-…

Adultmedicine.medical_specialtyTime FactorsPopulationPrenatal careWeight Gainlaw.inventionBody Mass Index03 medical and health sciences0302 clinical medicineRandomized controlled triallawPregnancyRisk FactorsmedicineHumans030212 general & internal medicineObesityeducationExerciseLife StylePregnancyeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryObstetricsNorwayPostpartum PeriodPregnancy OutcomeObstetrics and GynecologyPrenatal CareOdds ratioVitaminsmedicine.diseasePregnancy ComplicationsPhysical therapyFemalemedicine.symptombusinessBody mass indexWeight gainPostpartum periodBJOG : an international journal of obstetrics and gynaecology
researchProduct

Long-Term Results of Ileocecal Continent Urinary Diversion in Patients Treated With and Without Previous Pelvic Irradiation

2002

Patients who receive pelvic irradiation may require urinary diversion to manage complications resulting from progressive malignancy or radiotherapy. The choice of urinary diversion is an important issue and remains controversial. We characterized the long-term outcome of urinary diversion with a continent ileocecal reservoir in patients who received pelvic irradiation versus those who underwent urinary diversion without previous irradiation.Continent urinary diversion with an ileocecal reservoir (Mainz pouch 1) was performed in 36 irradiated patients in a 9-year period. Morbidity, mortality, the reoperative rate and parameters associated with the surgical procedure were determined at a medi…

Adultmedicine.medical_specialtyUrinary systemmedicine.medical_treatmentUrologyPelvisCystectomyPostoperative ComplicationsRisk FactorsmedicineHumansDerivationRadiation InjuriesAgedUrinary bladderbusiness.industryUrinary diversionUrinary Reservoirs Continentrespiratory systemMiddle AgedCombined Modality TherapySurgerymedicine.anatomical_structureUrinary Bladder NeoplasmsFemaleRadiotherapy AdjuvantPouchbusinessComplicationhuman activitiesContinent Urinary DiversionFollow-Up StudiesThe Journal of Urology
researchProduct

Sexual Function and Fertility of Women with Classic Bladder Exstrophy and Continent Urinary Diversion

2015

We evaluated the outcome in female patients with classic bladder exstrophy and continent urinary diversion for sexual function and fertility.We reviewed the medical records of female exstrophy patients who underwent continent urinary diversion in our department between 1969 and 2014. Patients were invited for followup examination and asked to complete questionnaires relating to sexual function, social integration and maternity.Of 38 eligible patients 29 (response rate 76%) with a followup of 22.3 years were included in study. Primary continent urinary diversion was done in 62% of patients and 38% underwent secondary continent urinary diversion after failed reconstruction of the exstrophic b…

Adultmedicine.medical_specialtyUrologymedicine.medical_treatmentmedia_common.quotation_subject030232 urology & nephrologyFertilityHuman sexualityUrinary DiversionPelvic Organ Prolapse03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsmedicineHumansRetrospective Studiesmedia_common030219 obstetrics & reproductive medicinebusiness.industryIncidenceGeneral surgeryBladder ExstrophyUrinary Reservoirs ContinentUrinary diversionRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryBladder exstrophySexual Dysfunction PhysiologicalTreatment OutcomeSexual dysfunctionFemalemedicine.symptomSexual functionbusinessInfertility Femalehuman activitiesContinent Urinary DiversionFollow-Up StudiesJournal of Urology
researchProduct

Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of …

2013

Study question Is it possible to distinguish metabolically healthy polycystic ovary syndrome (MH-PCOS) from metabolically unhealthy PCOS (MU-PCOS) by simple diagnostic tools such as body mass index (BMI), waist/hip ratio (WHR), at-risk category suggested by Androgen Excess Society (AES) and visceral adiposity index (VAI)? Summary answer VAI could be an easy and useful tool in clinical practice and in population studies for assessment of MU-PCOS. What is known already VAI is a good indicator of insulin sensitivity and cardiometabolic risk in oligo-ovulatory women with PCOS. Study design, size, duration We conducted a cross-sectional study of 232 women with PCOS in a university hospital setti…

Adultmedicine.medical_specialtyWaistAdolescentPopulationSettore MED/13 - EndocrinologiaDiagnosis DifferentialInsulin resistanceRisk FactorsInternal medicinemedicinePCOSHumanseducationAdiposityeducation.field_of_studybusiness.industryRehabilitationnutritional and metabolic diseasesObstetrics and GynecologyOdds ratioGlucose Tolerance Testmedicine.diseasePolycystic ovaryConfidence intervalCross-Sectional StudiesPhenotypeReproductive MedicineFemaleMetabolic syndromeInsulin ResistancebusinessEnergy MetabolismBody mass indexPolycystic Ovary SyndromeHuman reproduction (Oxford, England)
researchProduct

Physical inactivity from youth to adulthood and adult cardiometabolic risk profile

2020

Adults with a low physical activity (PA) level are at increased risk for cardiometabolic diseases, but little is known on the association between physical inactivity since youth and cardiometabolic health in adulthood. We investigated the association of persistent physical inactivity from youth to adulthood with adult cardiometabolic risk factors. Data were drawn from the ongoing Cardiovascular Risk in Young Finns Study with seven follow-ups between 1980 and 2011 (baseline age 3–18 years, n = 1961). Physical activity data from a standardized questionnaire was expressed as a PA-index. Using the PA-index, four groups were formed: 1)persistently physically inactive (n = 246), 2)decreasingly ac…

Adultmedicine.medical_specialtyelintavatWaistAdolescentlongitudinalEpidemiologymedicine.medical_treatmentinactive lifestylepitkittäistutkimusLower risk01 natural sciencesBody Mass Index03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsInternal medicinemedicineHumans030212 general & internal medicine0101 mathematicsChildExerciseFinland2. Zero hungerTriglyceridebusiness.industryInsulincardiovascular010102 general mathematicsPublic Health Environmental and Occupational Healthlapsuusmedicine.diseasechildhood [CVD]ObesityBlood pressurechemistryCardiovascular DiseasesChild Preschoolsydän- ja verisuonitauditnuoruusMetabolic syndromeSedentary BehaviorWaist CircumferencebusinessBody mass indexterveysriskitfyysinen aktiivisuus
researchProduct

Major gender difference in association of FTO gene variant among severely obese children with obesity and obesity related phenotypes.

2008

Recent studies have shown that SNPs in the FTO gene predispose to childhood and adult obesity. In this study, we examined the association between variants in FTO and KIAA1005, a gene that maps closely to FTO, and obesity, as well as obesity related traits among 450 well characterised severely obese children and 512 normal weight controls. FTO showed significant association with several obesity related traits while SNPs in KIAA1005 did not. When stratified by gender, the FTO variant rs9939609 showed association with obesity and BMI among girls (P = 0.006 and 0.004, respectively) but not among boys. Gender differences were also found in the associations of the FTO rs9939609 with obesity relat…

Adultmedicine.medical_specialtyendocrine system diseasesAdolescentmedicine.medical_treatmentBiophysicsAlpha-Ketoglutarate-Dependent Dioxygenase FTOSingle-nucleotide polymorphismBiochemistryFTO genePolymorphism Single NucleotideRisk AssessmentBody Mass IndexInsulin resistanceSex FactorsRisk FactorsInternal medicineDiabetes mellitusmedicinePrevalenceSNPHumansGenetic Predisposition to DiseaseObesitySex DistributionChildMolecular BiologySwedenbusiness.industryInsulinnutritional and metabolic diseasesGenetic VariationProteinspathological conditions signs and symptomsCell Biologymedicine.diseaseObesityEndocrinologyPhenotypeInsulin ResistancebusinessBody mass indexBiochemical and biophysical research communications
researchProduct

Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?

2018

For some time, it has been assumed that women with polycystic ovary syndrome (PCOS) are at increased risk of developing cardiovascular disease (CVD). This has largely been on the basis of having many risk factors, including abnormal lipid profile, insulin resistance, and markers of inflammation. However, despite having these and other risk factors, we argue here, in the view of the authors, that there is no credible evidence that there is greater CVD morbidity in all women with PCOS. We analyze the existing data and discuss that overall CVD risk decreases with age when more CVD events are likely to occur, and introduce the possibility that there may be some unknown inherent protective facto…

Adultmedicine.medical_specialtyendocrine system diseasesProtective factor030209 endocrinology & metabolismDiseaseRisk Assessment03 medical and health sciences0302 clinical medicineInsulin resistanceRisk FactorsDiabetes mellitusmedicineDiabetes MellitusHumansObesityMenstruation Disturbances030219 obstetrics & reproductive medicinebusiness.industryObstetricsHyperandrogenismAbsolute risk reductionnutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryObesityfemale genital diseases and pregnancy complicationsCardiovascular DiseasesFemalebusinessHyperandrogenismRisk Reduction BehaviorPolycystic Ovary SyndromeJournal of women's health (2002)
researchProduct